• Science and Research

  CF Lung Function Improved With Proteostasis’ Triple Combo, Trial Shows

  Posted by Cystic Fibrosis News Moderator on January 16, 2020 at 10:40 am

  

  A triple combination that includes dirocaftor (PTI-808) led to lung function improvements in CF patients with the F508del mutation, a Phase 2 trial shows. Read more here.

  What do you think about this study and its findings?

  Cystic Fibrosis News Moderator replied 4 years, 10 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply